Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The study on adverse events induced by pegylated interferon alpha plus ribavirin in chronic hepatitis c

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: KUO, Shu-Hui (National Cheng Kung University Hospital, Tainan, China Taiwan)
  • Co-author(s): Chang, Ting-Tsung (National Cheng Kung University Hospital, TAINAN, China Taiwan)
    Lin, Chia-Yin (National Cheng Kung University Hospital, TAINAN, China Taiwan)
    Tsai, Jui-Chen (National Cheng Kung University Hospital, TAINAN, China Taiwan)
  • Abstract:

    BACKGROUND The current standard therapy for hepatitis C is a combination of Pegylated interferon and Ribavirin. To avoid adverse reactions, dose reduction during the course of treatment is a commonplace. The tedious handling processes also bring inconveniences to the clinical practice. OBJECTIVE The major purpose of this study is to

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses